ABT: Abbott Laboratories Company Profile & Statistics

About

Abbott Labs discovers, develops, manufactures & sells a diversified line of health care products. Established Pharmaceuticals Division includes branded generics business in the emerging markets. Medical Devices unit includes the diabetes care, vision care & vascular businesses. Diagnostics unit manufactures and markets diagnostic systems and tests in four business lines core laboratory, molecular, point of care and rapid diagnostics. Nutrition unit includes a broad line of pediatric and adult nutritional products. Abbott acquired CFR Pharmaceuticals, Tendyne Holdings, Inc., St. Jude Medical and Alere Inc. On the other hand, Abbott sold its developed markets branded generics pharmaceuticals business to Mylan. Abbott retained the branded generics pharmaceuticals business in emerging markets. Abbott sold its animal health business to Zoetis Inc and divested its vision care business, Medical Optics, to Johnson & Johnson.

Info & Links

CEO

Robert B. Ford

Headquarters

100 ABBOTT PARK ROAD
ABBOTT PARK, IL 60064, UNITED STATES

Auditor

Ernst & Young LLP

Share holders

32,449

Employees

114,000

Abbott Laboratories Statistics

Valuation Measures

Market Capitalization²

198.11B

Enterprise Value

205.53B

Enterprise Value/EBITDA(ttm)

20.72

Price to Earnings Ratio(ttm)

24.87

Price to Sales(ttm)

4.73

Price to Book(mrq)

4.87

Price to Cash(ytd)

17.67

Profitability

Gross Margin(ttm)

55.55%

Operating Margin(ttm)

19.28%

Profit Margin(ttm)

13.97%

Return on Equity(ttm)

20.18%

Return on Invested Capital(ttm)

11.00%

Return on Assets(ttm)

10.84%

Income Statement

Revenue(ttm)

41.22B

Revenue Per Share(ttm)

23.76

Gross Profit(ttm)

22.90B

EBITDA(ttm)³

9.92B

Net Income Available to Common(ttm)

5.77B

Diluted EPS(ttm)

3.29

Share Statistics

Beta (5Y Monthly)

0.73

52-Week Change

10.75%

S&P 500 52-Week Change

25.68%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

1.73B

Dividend Yield

1.96%

Float⁴

1.72B

% Held by Insiders

1.10%

% Held by Institutions

75.18%

Balance Sheet

Total Cash(mrq)

7.79B

Total Cash Per Share(mrq)

4.49

Total Debt(mrq)

14.98B

Total Debt/Equity(mrq)

37.42%

Current Ratio(mrq)

1.60%

Quick Ratio(mrq)

1.14%

Book Value Per Share(mrq)

23.08

Cash Flow

Operating Cash Flow Per Share(ytd)

3.26

Free Cash Flow(ytd)

4.20B

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

ABT

Abbott Laboratories

Abbott Laboratories Profile